Physician profile
Christopher Thomas Johnson
NPI 1952780371
$4,943.54
in general payments reported to CMS, 2019-2025
25 companies · $1,467 in 2025
The $1,467 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $36.44 · 2021: $567 · 2022: $714 · 2023: $829 · 2024: $1,229 · 2025: $1,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,489 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,488.92 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,542.38 | 2020-2025 | Lensx, Clareon, Ora System Verifeye |
| Abbott Laboratories | $521.29 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Abbvie INC. | $510.33 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $493.31 | 2021-2025 | Eylea Hd |
| Glaukos Corporation | $372.18 | 2019-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| Apellis Pharmaceuticals, INC. | $308.56 | 2022-2025 | Syfovre |
| Amgen INC. | $225.16 | 2024-2025 | Tepezza |
| Microsurgical Technology, INC. | $210.58 | 2024 | |
| Mallinckrodt Hospital Products INC. | $162.72 | 2021 | |
| Alimera Sciences, INC. | $90.18 | 2019 | |
| Horizon Therapeutics Plc | $60.47 | 2021-2023 | Tepezza |
| Biotissue Holdings INC. | $60.23 | 2024-2025 | |
| Allergan, INC. | $55.92 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $52.97 | 2023 | Miebo, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $39.81 | 2024-2025 | Xdemvy |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $38.24 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Kala Pharmaceuticals, INC. | $36.27 | 2021 | |
| Aerie Pharmaceuticals, INC. | $31.11 | 2021 | |
| Rayner Intraocular Lenses Limited | $22.38 | 2024 | Omidria |
| Sun Pharmaceutical Industries INC. | $21.77 | 2021 | |
| Oyster Point Pharma, INC. | $20.07 | 2024 | Tyrvaya |
| Ivantis, INC | $19.73 | 2021 | |
| Dompe US, INC. | $18.38 | 2024 | Oxervate |
| Sight Sciences, INC. | $14.82 | 2024 | Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $14.68 | 2023 | Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.